VOYA Investment Management’s Dianthus Therapeutics DNTH Stock Holding History

VOYA Investment Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$510K	Buy	+6,077	New	+$352K	﹤0.01%	1709
2024 Q4	–	Sell	-7,961	Closed	-$218K	–	2744
2024 Q3	$218K	Sell	7,961 -155	-2%	-$4.32K	﹤0.01%	2440
2024 Q2	$210K	Buy	+8,116	New	+$195K	﹤0.01%	2441
2022 Q2	–	Sell	-743	Closed	-$34K	–	2805
2022 Q1	$34K	Hold	743	–	–	﹤0.01%	2625
2021 Q4	$53K	Sell	743 -32	-4%	-$3.22K	﹤0.01%	2740
2021 Q3	$90K	Hold	775	–	–	﹤0.01%	2757
2021 Q2	$121K	Buy	775 +145	+23%	+$26.6K	﹤0.01%	2740
2021 Q1	$119K	Hold	630	–	–	﹤0.01%	2647
2020 Q4	$79K	Buy	+630	New	+$71.4K	﹤0.01%	2601
2018 Q4	–	Sell	-15,550	Closed	-$2.99M	–	2562
2018 Q3	$2.99M	Sell	15,550 -134	-0.9%	-$28.2K	0.01%	962
2018 Q2	$3.39M	Buy	+15,684	New	+$3.54M	0.01%	918

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VOYA Investment Management's DNTH Position: Q1 2026 in Review

VOYA Investment Management opened a new position in Dianthus Therapeutics (DNTH) in Q1 2026: 6,077 shares worth $510K. The stake represents ﹤0.01% of the portfolio and ranks #1709 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in DNTH as recently as Q3 2024.

VOYA Investment Management first reported a position in DNTH in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.39M in Q2 2018. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

VOYA Investment Management held 6,077 shares of Dianthus Therapeutics worth $510K as of Q1 2026.
Dianthus Therapeutics was a new VOYA Investment Management position in Q1 2026.
Dianthus Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1709 holding.
VOYA Investment Management first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 11 quarters since.
VOYA Investment Management's Dianthus Therapeutics position peaked at $3.39M in Q2 2018.
241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.